UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of oncology, 2015-02, Vol.26 (2), p.313-320

2015

Volltextzugriff (PDF)

Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

Virchows Archiv : an international journal of pathology, 2004-08, Vol.445 (2), p.160-167

2004

Volltextzugriff (PDF)

Recurrent nerve palsy after thyroid operations--principal nerve identification and a literature review

Surgery, 1994-02, Vol.115 (2), p.139

1994

Volltextzugriff (PDF)

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

The New England journal of medicine, 2009-02, Vol.360 (7), p.679-691

2009

Volltextzugriff (PDF)

Abstract P3-03-24: ABCSG 33 - A multi center registry to evaluate the affect of macro metastasis in sentinel lymph node on survival

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-03-24

2019

Volltextzugriff (PDF)

Abstract P6-21-02: Withdrawn

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-21-02

2019

Volltextzugriff (PDF)

Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial

JOURNAL OF CLINICAL ONCOLOGY, 2018, Vol.36 (15_suppl), p.500-500

2018

Volltextzugriff (PDF)

Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax®) in the preoperative treatment of women with primary breast cancer (ABCSG-34)

Annals of oncology, 2017-09, Vol.28, p.v64-v65

2017

Volltextzugriff (PDF)

OC-0270 Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial

Radiotherapy and oncology, 2019-04, Vol.133, p.S132-S133

2019

Volltextzugriff (PDF)

260MO Long-term patient-reported outcomes in premenopausal women with the hormone receptor-positive breast cancer from ABCSG 22 Registry

ESMO open, 2023-05, Vol.8 (1), p.101356, Article 101356

2023

Volltextzugriff (PDF)

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS6-04-GS6-04

2018

Volltextzugriff (PDF)

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS3-01-GS3-01

2018

Volltextzugriff (PDF)

Improving survival rates for patients with colorectal cancer

British journal of surgery, 1992-06, Vol.79 (6), p.588-591

1992

Volltextzugriff (PDF)

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer

NEJM evidence, 2022-12, Vol.1 (12), p.EVIDoa2200162

2022

Volltextzugriff (PDF)

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-10-01

2017

Volltextzugriff (PDF)

Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

JOURNAL OF CLINICAL ONCOLOGY, 2015, Vol.33 (15_suppl), p.504-504

2015

Volltextzugriff (PDF)

Abstract S2-02: The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S2-S2-02

2016

Volltextzugriff (PDF)

Fracture Risk after Stopping Adjuvant Denosumab in Hormone Receptor Positive Breast Cancer Patients on Aromatase Inhibitor Therapy - an Analysis of 3,425 Postmenopausal Patients in the Phase III ABCSG-18 trial

JOURNAL OF BONE AND MINERAL RESEARCH, 2018, Vol.33, p.55

2018

Volltextzugriff (PDF)

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Clinical cancer research, 2008-04, Vol.14 (7), p.2082-2087

2008

Volltextzugriff (PDF)

Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital

International journal of colorectal disease, 1991-05, Vol.6 (2), p.111-114

1991

Volltextzugriff (PDF)

The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

CANCER RESEARCH, 2016, Vol.76

2016

Volltextzugriff (PDF)

Long‐term Prognosis for Colon Cancer Related to Consistent Radical Surgery: Multivariate Analysis of Clinical, Surgical, and Pathologic Variables

World journal of surgery, 2000-10, Vol.24 (10), p.1264-1270

2000

Volltextzugriff (PDF)

Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer

Breast cancer research and treatment, 2009-05, Vol.115 (2), p.373-380

2009

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(39)
Deutsch
(37)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

Recurrent nerve palsy after thyroid operations--principal nerve identification and a literature review

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Abstract P3-03-24: ABCSG 33 - A multi center registry to evaluate the affect of macro metastasis in sentinel lymph node on survival

Abstract P6-21-02: Withdrawn

Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial

Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax®) in the preoperative treatment of women with primary breast cancer (ABCSG-34)

OC-0270 Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial

260MO Long-term patient-reported outcomes in premenopausal women with the hormone receptor-positive breast cancer from ABCSG 22 Registry

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

Improving survival rates for patients with colorectal cancer

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Abstract S2-02: The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Fracture Risk after Stopping Adjuvant Denosumab in Hormone Receptor Positive Breast Cancer Patients on Aromatase Inhibitor Therapy - an Analysis of 3,425 Postmenopausal Patients in the Phase III ABCSG-18 trial

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital

The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Long‐term Prognosis for Colon Cancer Related to Consistent Radical Surgery: Multivariate Analysis of Clinical, Surgical, and Pathologic Variables

Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer

Suchergebnisse filtern